Beltzig, L.; Schwarzenbach, C.; Leukel, P.; Frauenknecht, K.B.M.; Sommer, C.; Tancredi, A.; Hegi, M.E.; Christmann, M.; Kaina, B.
Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells. Cancers 2022, 14, 2233.
https://doi.org/10.3390/cancers14092233
AMA Style
Beltzig L, Schwarzenbach C, Leukel P, Frauenknecht KBM, Sommer C, Tancredi A, Hegi ME, Christmann M, Kaina B.
Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells. Cancers. 2022; 14(9):2233.
https://doi.org/10.3390/cancers14092233
Chicago/Turabian Style
Beltzig, Lea, Christian Schwarzenbach, Petra Leukel, Katrin B. M. Frauenknecht, Clemens Sommer, Alessandro Tancredi, Monika E. Hegi, Markus Christmann, and Bernd Kaina.
2022. "Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells" Cancers 14, no. 9: 2233.
https://doi.org/10.3390/cancers14092233
APA Style
Beltzig, L., Schwarzenbach, C., Leukel, P., Frauenknecht, K. B. M., Sommer, C., Tancredi, A., Hegi, M. E., Christmann, M., & Kaina, B.
(2022). Senescence Is the Main Trait Induced by Temozolomide in Glioblastoma Cells. Cancers, 14(9), 2233.
https://doi.org/10.3390/cancers14092233